Manning & Napier Advisors LLC Royalty Pharma PLC Transaction History

Manning & Napier Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 22, 2025	SELL	$25.75 - $33.86 $1.15 Million - $1.51 Million	-44,505 Reduced 54.91%	36,549 $1.14 Billion
Q4 2024 Jan 23, 2025	SELL	$24.28 - $28.39 $1.27 Million - $1.49 Million	-52,510 Reduced 39.31%	81,054 $2.07 Billion
Q3 2024 Oct 17, 2024	SELL	$25.63 - $29.27 $1.6 Million - $1.82 Million	-62,289 Reduced 31.8%	133,564 $3.78 Billion
Q2 2024 Jul 11, 2024	BUY	$26.26 - $29.9 $5.14 Million - $5.86 Million	195,853 New	195,853 $5.16 Billion

535

303M

1.34M

252K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $17.1B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Manning & Napier Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Manning & Napier Advisors LLC with notifications on news.